• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNITED THERAPEUTICS TYVASO INHALATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNITED THERAPEUTICS TYVASO INHALATION SYSTEM Back to Search Results
Model Number TD100
Device Problems No Display/Image (1183); Device Emits Odor (1425); Smoking (1585)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
This case is a spontaneous report from united states of america received from a consumer via a speciality pharmacy.The patient was a (b)(6)-year-old female who first received tyvaso (treprostinil) on (b)(6) 2013 for chronic pulmonary heart disease.Inhaled (ih) treprostinil dosage was 54 micrograms (9 breaths), four times daily at the time of the event relevant medical history and concomitant medications were not reported.On an unspecified date in 2014, the patient reported that she tried her car adapter and it worked for first three breaths.Then the screen went blank, and the adapter started smoking.She reported that the wiring gave burning smell with car charger.Device model number was reported as td100.The outcome of the event device malfunction unknown.Manufacturer report number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TYVASO INHALATION SYSTEM
Type of Device
TYVASO INHALATION SYSTEM
Manufacturer (Section D)
UNITED THERAPEUTICS
MDR Report Key4217261
MDR Text Key4995643
Report NumberMW5038880
Device Sequence Number1
Product Code CAF
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Type of Report Initial
Report Date 06/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/12/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberTD100
Patient Sequence Number1
Treatment
TYVASO (TREPROSTINIL SODIUM) INHALATION GAS,; 0.6MG/ML
Patient Age71 YR
Patient Weight77
-
-